ELV Stock Summary and Trading Ideas (Elevance Health | NYSE:ELV)

Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.

Elevance Health trades on the NYSE stock market under the symbol ELV.

As of February 7, 2025, ELV stock price climbed to $393.57 with 462,117 million shares trading.

ELV has a beta of 0.35, meaning it tends to be less sensitive to market movements. ELV has a correlation of 0.03 to the broad based SPY ETF.

ELV has a market cap of $91.26 billion. This is considered a Large Cap stock.

Last quarter Elevance Health reported $45 billion in Revenue and $3.84 earnings per share. This beat revenue expectation by $269 million and missed earnings estimates by -$.02.

The top ETF exchange traded funds that ELV belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.

ELV has underperformed the market in the last year with a price return of -19.0% while the SPY ETF gained +23.2%. ELV has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -7.9% and -1.9%, respectively, while the SPY returned +2.1% and -1.4%, respectively.

ELV support price is $382.97 and resistance is $397.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ELV shares will trade within this expected range on the day.